Meunier A, Hernandez-Castro J, Chahley N, Communal L, Kheireddine S, Koushki N
Commun Med (Lond). 2025; 5(1):33.
PMID: 39900650
PMC: 11790846.
DOI: 10.1038/s43856-024-00702-9.
Rabadi I, Carpentieri D, Wang J, Zenhausern F, Gu J
Micromachines (Basel). 2024; 15(4).
PMID: 38675332
PMC: 11051955.
DOI: 10.3390/mi15040521.
Zheng C, Dai P, You H, Xian Z, Su W, Wu S
Anal Sci. 2024; 40(7):1239-1248.
PMID: 38598051
DOI: 10.1007/s44211-024-00553-3.
Cardona S, Mostafazadeh N, Luan Q, Zhou J, Peng Z, Papautsky I
Micromachines (Basel). 2023; 14(9).
PMID: 37763828
PMC: 10538085.
DOI: 10.3390/mi14091665.
Braun C, Schmoor C, Timme-Bronsert S, Fichtner-Feigl S, Hoeppner J, Kulemann B
J Cancer. 2023; 14(11):2152-2160.
PMID: 37497409
PMC: 10367926.
DOI: 10.7150/jca.82668.
Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik M, Sagar P, Shaik N, Randhawa N
Int J Mol Sci. 2023; 24(13).
PMID: 37445822
PMC: 10341811.
DOI: 10.3390/ijms241310644.
Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time.
Ali A, Adams D, Kasabwala D, Tang C, Ho T
Sci Rep. 2023; 13(1):10544.
PMID: 37386095
PMC: 10310728.
DOI: 10.1038/s41598-023-37671-3.
Leukocyte Depletion and Size-Based Enrichment of Circulating Tumor Cells Using a Pressure-Sensing Microfiltration Device.
Onoshima D, Hase T, Kihara N, Kuboyama D, Tanaka H, Ozawa N
ACS Meas Sci Au. 2023; 3(2):113-119.
PMID: 37090261
PMC: 10120030.
DOI: 10.1021/acsmeasuresciau.2c00057.
From the teapot effect to tap-triggered self-wetting: a 3D self-driving sieve for whole blood filtration.
Li Y, Li X, Zhang L, Luan X, Jiang J, Zhang L
Microsyst Nanoeng. 2023; 9:30.
PMID: 36960347
PMC: 10027851.
DOI: 10.1038/s41378-023-00490-7.
High-performance glass filters for capturing and culturing circulating tumor cells and cancer-associated fibroblasts.
Tanaka H, Iwata D, Shibata Y, Hase T, Onoshima D, Yogo N
Sci Rep. 2023; 13(1):4130.
PMID: 36914725
PMC: 10011408.
DOI: 10.1038/s41598-023-31265-9.
Recent advances in micro-/nanostructure array integrated microfluidic devices for efficient separation of circulating tumor cells.
Kang H, Xiong Y, Ma L, Yang T, Xu X
RSC Adv. 2022; 12(54):34892-34903.
PMID: 36540264
PMC: 9724214.
DOI: 10.1039/d2ra06339e.
Phenotyping of rare circulating cells in the blood of non-metastatic breast cancer patients using microfluidic Labyrinth technology.
Pore A, Bithi S, Zeinali M, Navaid H, Nagrath S, Layeequr Rahman R
Biomicrofluidics. 2022; 16(6):064107.
PMID: 36536791
PMC: 9759355.
DOI: 10.1063/5.0129602.
Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination.
Noubissi Nzeteu G, Geismann C, Arlt A, Hoogwater F, Nijkamp M, Meyer N
Cancers (Basel). 2022; 14(22).
PMID: 36428576
PMC: 9688619.
DOI: 10.3390/cancers14225483.
A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?.
Rahmanian M, Sartipzadeh Hematabad O, Askari E, Shokati F, Bakhshi A, Moghadam S
J Adv Res. 2022; 47:105-121.
PMID: 35964874
PMC: 10173300.
DOI: 10.1016/j.jare.2022.08.005.
A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.
Sulaiman R, De P, Aske J, Lin X, Dale A, Vaselaar E
Cancers (Basel). 2022; 14(12).
PMID: 35740537
PMC: 9221448.
DOI: 10.3390/cancers14122871.
Clinical Applications of Cancer-Associated Cells Present in the Blood of Cancer Patients.
Tang C, Adams D
Biomedicines. 2022; 10(3).
PMID: 35327389
PMC: 8945841.
DOI: 10.3390/biomedicines10030587.
Integrated microdevice with a windmill-like hole array for the clog-free, efficient, and self-mixing enrichment of circulating tumor cells.
Li H, Li J, Zhang Z, Guo Z, Zhang C, Wang Z
Microsyst Nanoeng. 2022; 8:23.
PMID: 35251688
PMC: 8844004.
DOI: 10.1038/s41378-021-00346-y.
Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis.
Xiao J, Pohlmann P, Isaacs C, Weinberg B, He A, Schlegel R
Biomedicines. 2021; 9(9).
PMID: 34572297
PMC: 8467892.
DOI: 10.3390/biomedicines9091111.
Cell-Main Spectra Profile Screening Technique in Simulation of Circulating Tumour Cells Using MALDI-TOF Mass Spectrometry.
Chiangjong W, Bhakdi S, Woramongkolchai N, Vanichapol T, Pongsakul N, Hongeng S
Cancers (Basel). 2021; 13(15).
PMID: 34359679
PMC: 8345129.
DOI: 10.3390/cancers13153775.
Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
Vogl T, Riegelbauer L, Oppermann E, Kostantin M, Ackermann H, Trzmiel A
PLoS One. 2021; 16(2):e0246527.
PMID: 33577574
PMC: 7880472.
DOI: 10.1371/journal.pone.0246527.